TenNor Therapeutics is a clinical-stage company focused on developing innovative therapies to address unmet needs in infectious diseases. The company is advancing rifasutenizol, a potential groundbreaking treatment for Helicobacter pylori infection, marking a significant development in this area after more than three decades.
